Jan 23, 2017 12:01 pm UTC| Business
BEVERLY, Mass., Jan. 23, 2017 -- Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), a clinical stage biopharmaceutical company developing innovative therapies with dermatology, oncology, anti-inflammatory, and...
Jan 23, 2017 12:01 pm UTC| Business
BEVERLY, Mass., Jan. 23, 2017 -- Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), a clinical stage biopharmaceutical company developing innovative therapies with dermatology, oncology, anti-inflammatory, and...
Jan 23, 2017 12:00 pm UTC| Business
ADMA to secure: Ownership and control of U.S. based Immune Globulin manufacturing facility FDA licensed products portfolio with immediate and on-going commercial sales $40M in Equity/Debt Financing from Biotest AG;...
Jan 23, 2017 12:00 pm UTC| Business
VANCOUVER, British Columbia , Jan. 23, 2017 -- MGX Minerals Inc. (“MGX” or the “Company”) (CSE:XMG)(FKT:1MG)(OTC:MGXMF) is pleased to announce formation of the PetroLithium Corporation of America, a 100% owned U.S....
Aptose Prioritizes Development of CG’806 First-in Class FLT3/BTK Inhibitor
Jan 23, 2017 12:00 pm UTC| Business
Pauses APTO-253 to Elucidate Manufacturing Setback -- Company to Host Conference Call Today at 8:30 AM ET -- SAN DIEGO and TORONTO, Jan. 23, 2017 -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage...
The Joint Corp. Appoints Jorge Armenteros VP of Operations
Jan 23, 2017 12:00 pm UTC| Business
SCOTTSDALE, Ariz., Jan. 23, 2017 -- The Joint Corp. (NASDAQ:JYNT), a national operator, manager and franchisor of chiropractic clinics, today announced that as part of its effort to sustain its position as a leader in...
Forbes Commences Voluntary Chapter 11; Files Prepackaged Reorganization Plan
Jan 23, 2017 12:00 pm UTC| Business
Operations to Continue Uninterrupted; Vendors and Trade Creditors Paid in Full $280 Million of Unsecured Notes To Be Exchanged for Equity in Reorganized Company ALICE, Texas, Jan. 23, 2017 -- Forbes Energy...